CliffBio
small molecule

ASPIRIN AND DIPYRIDAMOLE

ASPIRIN; DIPYRIDAMOLE

Loss of exclusivity—loss of exclusivity
CompanyGLENMARK SPECIALTY SA

Drug detail

Brand nameASPIRIN AND DIPYRIDAMOLE
Active ingredientASPIRIN; DIPYRIDAMOLE
Strength25MG;200MG
Dosage formCAPSULE, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalMay 2019
Marketing statusRX

More from GLENMARK SPECIALTY SA

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

ASPIRIN AND DIPYRIDAMOLE patent cliff — loss of exclusivity — | CliffBio